CD133 expression is associated with less DNA repair, better response to chemotherapy, and survival in ER-positive/ER-negative breast cancer

被引：0
|
作者：
Sato, Takumi
Oshi, Masanori
Lee, Jing
Roy, Arya M.
Chida, Kohei
Endo, Itaru
Obayashi, Masato
Takabe, Kazuaki
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2520
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer
    Sato, Takumi
    Oshi, Masanori
    Huang, Jing Li
    Chida, Kohei
    Roy, Arya Mariam
    Endo, Itaru
    Takabe, Kazuaki
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
  • [2] CD133 Expression in ER-positive/HER2-negative Breast Cancer is Prognostic for Survival
    Huang, J.
    Oshi, M.
    Takabe, K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S57 - S57
  • [3] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [4] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    [J]. Breast Cancer Research, 7
  • [5] Low Estrogen Receptor ( ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Zhu, Li
    Diego, Emilia J.
    Johnson, Ronald R.
    Soran, Atilla
    Dabbs, David J.
    Clark, Beth Z.
    Puhalla, Shannon L.
    Jankowitz, Rachel C.
    Brufsky, Adam M.
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 34 - 42
  • [6] AgNOR analysis of ER-positive and ER-negative cells in breast cancer.
    Guski, H
    Winzer, KJ
    Hufnagl, P
    Gunther, L
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 341 - 341
  • [7] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    [J]. PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [8] Oxysterol signalling is retained in ER-negative and supressed in ER-positive breast cancer
    Hutchinson, Samantha
    Battaglia, Sebastiano
    Roberg-Larsen, Hanne
    Lianto, Priscilia
    Hughes, Thomas
    Thorne, James
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE2) : E142 - E142
  • [9] Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer
    Witton, CJ
    Hawe, SJK
    Cooke, TG
    Bartlett, JMS
    [J]. HISTOPATHOLOGY, 2004, 45 (01) : 47 - 54
  • [10] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
12345